Nucala is Now Approved For 4 Rare Eosinophil-Based Diseases in Europe
GlaxoSmithKline has recently announced their new approval of Nucala by the European Commission. This therapy has been approved for three new diseases, all of which are driven by eosinophils. Nucala is…